The clinical importance of pharmacogenetics.
These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California Medical Center, San Francisco. Taken from transcriptions, they are prepared by Drs. Martin J. Cline and Hibbard E. Williams, Associate Professors of Medicine, under the direction of Dr. Lloyd H. Smith, Jr., Professor of Medicine and Chairman of the Department of Medicine.
D000328:Adult; D000368:Aged; D002675:Child, Preschool; D002869:Chromosome Aberrations / Q000139:chemically induced; D025063:Chromosome Disorders; D000013:Congenital Abnormalities / Q000150:complications; D004342:Drug Hypersensitivity; D004361:Drug Tolerance; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005838:Genotype; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000209:etiology; D006461:Hemolysis; D006801:Humans; D007538:Isoniazid / Q000378:metabolism; D008297:Male; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010597:Pharmacogenetics; D011319:Primaquine / Q000494:pharmacology; D014859:Warfarin / Q000378:metabolism
D004364:Pharmaceutical Preparations; D014859:Warfarin; D011319:Primaquine; D007538:Isoniazid